Results 111 to 120 of about 33,645 (162)
Some of the next articles are maybe not open access.
American Journal of Medicine, 2005
Among the drugs affecting the thyroid gland, no drug has puzzled, and at the same time fascinated, endocrinologists more than amiodarone. Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties. It is very rich in iodine, with a 100-mg tablet containing an amount of iodine that is 250 times the recommended ...
David Cooper, Shehzad Basaria
exaly +3 more sources
Among the drugs affecting the thyroid gland, no drug has puzzled, and at the same time fascinated, endocrinologists more than amiodarone. Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties. It is very rich in iodine, with a 100-mg tablet containing an amount of iodine that is 250 times the recommended ...
David Cooper, Shehzad Basaria
exaly +3 more sources
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 1987
We descibe the use and interference of ...
De Rosa, Giovina +2 more
openaire +5 more sources
We descibe the use and interference of ...
De Rosa, Giovina +2 more
openaire +5 more sources
Endocrine Practice, 1998
To review the amiodarone-associated alterations in thyroid hormone metabolism and thyroid function and compare them with the effects of inorganic iodide. To clarify the pathophysiologic features and treatment of amiodarone-associated hypothyroidism and thyrotoxicosis.Amiodarone, an iodinated benzofuran, is an important antianginal and antiarrhythmic ...
S B, Seminara, G H, Daniels
openaire +2 more sources
To review the amiodarone-associated alterations in thyroid hormone metabolism and thyroid function and compare them with the effects of inorganic iodide. To clarify the pathophysiologic features and treatment of amiodarone-associated hypothyroidism and thyrotoxicosis.Amiodarone, an iodinated benzofuran, is an important antianginal and antiarrhythmic ...
S B, Seminara, G H, Daniels
openaire +2 more sources
American Heart Journal, 1983
The single-dose pharmacokinetics of amiodarone have been studied in volunteer subjects given 400 mg doses by the intravenous and oral routes. The data show the compound to have a very large volume of distribution, a low total clearance, and a long and variable terminal elimination half-life.
D W, Holt +3 more
openaire +2 more sources
The single-dose pharmacokinetics of amiodarone have been studied in volunteer subjects given 400 mg doses by the intravenous and oral routes. The data show the compound to have a very large volume of distribution, a low total clearance, and a long and variable terminal elimination half-life.
D W, Holt +3 more
openaire +2 more sources
Annals of Internal Medicine, 1983
Excerpt To the editor: Marchlinski and associates (1) have recently reported pneumonitis in four patients after treatment with amiodarone and, on the basis of their ultrastructural findings, have q...
J, Antolin +3 more
openaire +2 more sources
Excerpt To the editor: Marchlinski and associates (1) have recently reported pneumonitis in four patients after treatment with amiodarone and, on the basis of their ultrastructural findings, have q...
J, Antolin +3 more
openaire +2 more sources
Neurology, 1983
Amiodarone, a drug used to treat refractory cardiac arrhythmias, produced a peripheral neuropathy in 5 of 50 cases (10%). Although the neuropathy may be severe, it tends to improve with lowering of the dosage or discontinuation of the medication.
A, Martinez-Arizala +4 more
openaire +2 more sources
Amiodarone, a drug used to treat refractory cardiac arrhythmias, produced a peripheral neuropathy in 5 of 50 cases (10%). Although the neuropathy may be severe, it tends to improve with lowering of the dosage or discontinuation of the medication.
A, Martinez-Arizala +4 more
openaire +2 more sources
Ophthalmologica, 2010
6 cardiac patients were found to present various degrees of corneal involvement following systemic treatment with amiodarone. The clinical pattern of the keratopathy, its benign course and the pathophysiology are discussed. Lacrimal insufficiency or incomplete blinking seem to contribute to the severity of the keratopathy.
V, Feiler-Ofry +3 more
openaire +2 more sources
6 cardiac patients were found to present various degrees of corneal involvement following systemic treatment with amiodarone. The clinical pattern of the keratopathy, its benign course and the pathophysiology are discussed. Lacrimal insufficiency or incomplete blinking seem to contribute to the severity of the keratopathy.
V, Feiler-Ofry +3 more
openaire +2 more sources
Annals of Internal Medicine, 1985
Excerpt To the editor: Mazonson and associates (1) report that myxedema is not an uncommon occurrence during amiodarone therapy.
L E, Alves, E P, Rose, T B, Cahill
openaire +2 more sources
Excerpt To the editor: Mazonson and associates (1) report that myxedema is not an uncommon occurrence during amiodarone therapy.
L E, Alves, E P, Rose, T B, Cahill
openaire +2 more sources